chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient is fully vaccinate.  Patient complains of shortness of breath.  Was diagnosed with COVID in late December.  States that she was recently hospitalized for COVID-19.  States that she was discharged yesterday. On arrival patient was noted to be 80% on room air. Treatment: oxygen, IV Decadron, Breo, albuterol.  Positive D dimer, CT of the chest for IV contrast negative for PE, on Lovenox.  Discharged home.
Severe calf pain, leg numbness, extremely nauseous, almost passed out several times(tunnel vision, dizzy, lightheaded). Arrived at a patient first, but symptoms rapidly worsened, so I went to the hospital. IV fluid was given and sodium chloride 0.9% IV bolus was prescribed.
Rash left side of body past 4-5 days. Classic error zoster-like rash. No history of chickenpox received varicella immunization 25 months ago. Acyclovir.
severe abd pains like labor pains, nausea, lack of appetite, no other family had sx;
TERRIBLE BODY ACHES; CHILLS; FEVER; HEADACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the subject experienced terrible body aches, chills, fever, and headache. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 100-101. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, terrible body aches, chills and headache was not reported. This report was non-serious.
headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of HEADACHE (headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was provided. No treatment medication details was provided.
Large, diffuse area of redness and tenderness. Patient reported symptoms 8/22/2018 and states the area is not warm or grossly painful.
Felt  Nausea, hot, sweaty right after injection- Also c/o ringing  in ears briefly.
Immediate symptoms of red, hot blotchy skin face neck and chest with hives behind bilateral ears within 20 minutes tightening and heaviness of chest which resolved within an hour. Continued symptoms of headache and fatigue. Four days after vaccine experienced vertigo upon waking that morning lasting 6 hours. Six days after vaccine experienced pain and swelling in left arm pit with a painful enlarged lymph node. Today is day eight post vaccine and still experiencing painful swollen left armpit.
bilateral blood clots in legs that then went to lungs then went into BLAST crisis; bilateral blood clots in legs that then went to lungs then went into BLAST crisis; bilateral blood clots in legs that then went to lungs then went into BLAST crisis; Patient with myeloid leukaemia (CML) and WBCs abnormal received BNT162B2; Patient with myeloid leukaemia (CML) and WBCs abnormal received BNT162B2; This is a spontaneous report from a contactable consumer (patient). An 82-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection (lot number and expiration date unknown) via an unspecified route of administration in the left arm on 02Feb2021, 13:00PM (at 82 years old) at a single dose for COVID-19 immunization. The patient was vaccinated in the Nursing Home/Senior Living Facility. The patient's medical history included myeloid leukaemia (CML) diagnosed a few months earlier, WBCs abnormal, blood pressure, and heart surgery valve repair. The patient has no known allergies. Concomitant medications included atorvastatin, carvedilol, vitamin d nos, dasatinib monohydrate (SPRYCEL) from an unknown date to help get WBCs back in normal range; cyanocobalamin (VITAMIN B12), and cetirizine hydrochloride (ZYRTEC), all were received within 2 weeks of vaccination. At 82 years old, the patient received the first dose of BNT162B2 (lot number and expiration date unknown) via an unspecified route of administration in the left arm on 12Jan2021 at a single dose for COVID-19 immunization. The patient was not diagnosed with COVID prior to vaccination and did not receive any other vaccines within 4 weeks prior to BNT162B2. It was unknown if patient was tested for COVID post vaccination. On Friday (unknown date in Feb2021), patient's WBC was 150,000 and on Saturday (unknown date in Feb2021), patient had bilateral blood clots in legs that then went to lungs then went into BLAST crisis. The adverse events resulted in emergency room/department or urgent care as well as hospitalization due to life threatening illness (immediate risk of death from the events). The patient was hospitalized for 12 days. Therapeutic measures which include steroids, blood thinners, and lots of other meds were administered. Outcome of the events "patient's WBC was 150,000" and "bilateral blood clots in legs that then went to lungs then went into BLAST crisis" was recovering.  Information on the lot/ batch number has been requested.
Sharp pain in arm almost right away. Then arm was sore and swollen at injection site next day. Swelling got worse and then arm below elbow had a large swelling site next day. The pinkie and next finger were very painful and whole arm and neck continue to hurt. Still having same problem. Will be seeing neurologist soon.
Left arm was  injection location, was very sore; Left arm is the injection location, swollen; Left arm was the injection location, red; Left arm was the injection location, hot to the touch.; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 04May2021 at 13:00 (at the age of 58-year-old) as a 0.3 mL single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 13Apr2021 at 13:00 (at the age of 58-year-old) as a 0.3 mL single dose for COVID-19 immunisation. On 07May2021, the patient experienced left arm, which was her injection location, was very sore, swollen, red and hot to the touch. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left arm which was injection location, was very sore, swollen, red and hot to the touch was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
SUSPECTED COVID-19 INFECTION; INAPPROPRIATE SCHEDULE OF VACCINATION; OFF-LABEL USE; This spontaneous report received from a patient via a company representative via social media concerned a 69-year-old of unspecified sex, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient was previously received covid-19 vaccine ad26.cov2.s (form of admin, route of admin and batch number were not reported ,expiry: unknown), 1 in total, dose was not reported, start therapy date were not reported for prophylactic vaccination (Dose number in series 1). It was unknown whether patient had any adverse event following vaccination with covid-19 vaccine ad26.cov2.s The patient received booster of covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin and batch number were not reported, expiry: unknown) 1 total, dose and start therapy date were not reported for prophylactic vaccination(Dose number in series 2). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers.  No concomitant medications were reported.  On an unspecified date, the patient had a mild case of Covid (suspected covid-19 infection) which is due to inappropriate schedule of vaccination and off label use were (all events dose number in series 2). As per the report "The booster was the same. I just went to a pharmacy and got a J and J like it was my first. At 69, I wasn't waiting for another week for approval.  Now I have a mild case of Covid thanks to someone who worked in a small salon and did not wear a mask. I was to babysit her child and my grandkids. No one knew she did not wear a mask. Pretty sure my 2 year old grandchild".  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected covid-19 infection, inappropriate schedule of vaccination and off label use were not reported. This report was non-serious. This report was associated with a product quality complaint: 90000207824, 90000207825. The suspected product quality complaint has been confirmed to be voided (did not meet pqc criteria as reported complaints were adverse events). based on the PQC evaluation/investigation performed.; Sender's Comments: V0-  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
I felt discomfort I felt like I was having a session of gout and I noticed my leg swell up bigger than I have ever seen. I had to get x-rays  prednisone for 5 days and that took care of the issues. I could then walk again and I was finally out of pain. The x-ray tech told me this was common for the second shot. I got a flu shot 5 mos later and my other leg (left foot/ankle ) swell up and I had crazy pain. I had to go to back to the Dr, get more x-ray and after 5 days of prednisone I was fine.
Patient developed low grade fevers approximately 5 days after immunization given. On day 7 and day 10, patient had two short self limited generalized tonic clonic seizures. Evaluation by CT and EEG was NL. Temperature with seizures 100.9 and 100.6.
No additional AE; an improperly stored vaccine was administered to a patient; This spontaneous report was received from a medical assistant referring to a patient of unspecified age and gender. Information regarding the patient's medical history, concurrent conditions, concomitant therapies and previous drug reactions or allergies was not provided.   On 08-AUG-2022, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) 2 milliliters (mL) once, as prophylaxis (route of administration, vaccine scheme and anatomical site were not reported; lot number 1879870 has been verified to be valid, expiration date reported and established as 16-OCT-2023). The vaccine was exposed to a temperature excursion of 34.5 degrees Fahrenheit (F) during a time frame of 1 hour and 7 minutes (product storage error). In addition, the vaccine was exposed to a previous temperature excursion of 66.7 F for 13 hours 52 minutes.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2210USA005936: US-009507513-2210USA005917:MSD US-009507513-2210USA005937: US-009507513-2210USA005929: US-009507513-2210USA005979: US-009507513-2210USA005624: US-009507513-2210USA005942: US-009507513-2210USA005994: US-009507513-2210USA005996: US-009507513-2210USA006007:
Following morning after vaccine had AM vertigo mild  resolved. Next morning on 21 st  had severe vertigo and tinnitus.  Lasted most of the morning . On 10//22/23. No AM vertigo
I had an annual mammogram. When I went for the 3D mammogram, they told me they had to do the right side again. I thought it was just blurry, but they said something. Then, I got a sonogram and did not find it physically. I had a biopsy, and I got a second open when they said to get chemo and tumor removal. The tumor was bigger then triple positive. I opted for a double mastectomy and went to chemo. I had surgery July 22, 2022. I finished chemo at the end of November 2021. I am still on antibodies until September 1.
Maternal aunt called on 07/30/2004 at 4 pm to report that client had a rash all over his body and had difficulty swallowing.  Gave history of fever.  Denied signs or symptoms of respiratory distress.
On May 23 started feeling sore throat and fatigue,tested negative on an at home antigen test but by May 25 the sore throat was severe, had 101.1 degree fever, chills, nausea, headache, overall body aches and tested positive on at home antigen test so I went to Mather Hospital where they gave me an infusion of monoclonal antibodies.  I slept almost the entire day and the next day I felt a little better.  Fever broke, chills subsided, still sore throat, little appetite and coughing and congestion.
Rash to upper chest, armpits, abdomen, lower back, inner thighs, and pubic area. At the time of this report, symptoms are ongoing.
Firm erythematous circ. area 2 in x 1 inch to (L) thigh at vaccination site. No fever. Placed on KEFLEX (250/5) 4.2 ml po TID x 10 days.
I have a pre-existing condition, atrial fibrilation, controlled through daily dose of Metoprolol 25 mg with no symptoms. After each does of the COVID19 vaccine I experienced the onset of atrial fibrilation within 1-2 days that would last for more than one week and eventually subside.
redness, swelling, increased warmth  at site immediately after vaccination  G2P0 at 32W4D; EDC 12/12/2021, uncomplicated pregnancy   Observed for 30 mins, symptoms improved steadily, no further testing/treatment provided
Swelling in arm 40mm, hot, pain, upset stomach, lasted 2 days Treatment: Ice, Ibuprofen, Tylenol
headache, and severe brain zaps that started at night, with every move. They lasted till the late morning of the next day.  Fatigue that lasted next day.  Tinnitus started with headache and still persists.  Whole body itching started 3 days after vaccine and still persists. No rush.
Chief Complaint   Generalized weakness, cough, shortness of breath  History of Present Illness     Patient is a 69 years old male with medical history of Kappa light chain amyloidosis, renal biopsy-proven (currently on daratumumab + CyBorD), ESRD on HD-MWF, paroxysmal a-fib (previously on dofetilide now on amiodarone & Eliquis), HLD, HTN, CVA 2017, DM2, hx of CVA, OSA (on CPAP) presented to ER on 8/12/2021 with a history of worsening generalized weakness for 1 day, productive cough with greenish sputum for 4 days.  Patient reports he started to have cough with yellowish-greenish sputum starting from 8/9/2021.  He endorses associated mild shortness of breath and wheezing and chills but, denies associated chest pain, palpitation, fever, nausea, vomiting, incision bowel bladder habit.  Since this morning, he has been feeling very tired to the point that he could not walk prompting his wife brought him to the ER.  He endorses associated dizziness, lightheaded.  Patient is fully vaccinated against Covid-19 (2/2021), no known history of exposure.  Vitals at presentation is stable, heart rate at 80s, blood pressure at 100s/70s.  Saturating at 90s in room air.  Labs notable for WBC 9.4, hemoglobin stable at 11.5, platelet 91, CMP notable for creatinine 4.5.  Covid rapid antigen positive, CRP 2.99.  Chest x-ray notable for bibasilar airspace opacities consistent with Covid-19 pneumonia versus aspiration versus bacterial pneumonia.  Moderate right pleural effusion with compressive atelectasis. EKG sinus rhythm, without acute ischemic changes.  QTc 487.  Patient has been admitted to Hemet oncology service for management of Covid pneumonia as well as for inpatient hemodialysis.
Moderate to severe radiating right leg pain since late May, 2021, w/ no known cause. Recent swelling and stiffness in right knee. OTC meds for pain and cyclobenzaprine. Physical Therapy.
This is a spontaneous report from a contactable healthcare professional who reported on behalf of a physician through a Company representative. A 18-year-old male patient received TRUMENBA (lot L131515, expiry date 31Jul2016) on 17May2016 at 2:44 PM, at 0.5 ml single, intramuscular in left deltoid. The patient did not receive any other vaccine on the same day. The patient medical history was none. On 10May2016 the patient took second dose of MENACTRA (Manufacturer Sanofi; Lot U526OAA) intramuscularly in the left arm, hepatitis A vaccine (manufactured by Merck; lot LO45713) intramuscularly in the left arm and GARDASIL (Manufacturer: Merck, lot LO19297) intramuscularly in the right arm. The patient experienced chill on 17May2016 with outcome of recovered, fever on 17May2016 with outcome of recovered, extreme headache on 17May2016 with outcome of recovered, sore throat on 17May2016 with outcome of recovered, soreness on 17May2016 with outcome of recovered, fatigue on an unspecified date with outcome of unknown, muscle pain on an unspecified date with outcome of unknown, not feeling well on an unspecified date with outcome of unknown. The patient came to the doctor's office on 18May2016 due to the events. The patient was advised to call back if the events continued. Treatment for events included: MOTRIN every 6 hours, increase fluids and ice/compression to the area. Follow up (19May2016 and 23May2016): New information from a contactable healthcare professional who reported on behalf of a physician through a Company representative includes: reporter type (case medically confirmed), vaccine lot number, expiry date, administration date, route and anatomical location of administration, concomitant vaccines, additional events 'fatigue', 'muscle pain', 'not feeling well', treatment received. Follow-up (06Jun2016): additional information received from the same contactable physician includes dose of vaccine previously administered. Follow-up attempts completed. No further information expected.
Local reaction in arm. Area of induration, warm and swelling. No other signs or symptoms of infection.
Two weeks after vaccine Headache for six days Followed by tinnitus  Tinnitus ongoing for ten days and has not stopped
Seen in office on 3/18/03 with a temperature of 100F, fussy, not eating or sleeping, emesis X 1, diaphoretic and swelling at injection sites.
After the first vax and continuing up to today, I have experienced dry and flaking skin on my face, in my scalp, in my ears, and also my lower leg/shin area. Very strong itch in the scalp and ears particularly. I have not sought medical advice as of yet.
skin allergy; This spontaneous case was reported by a consumer and describes the occurrence of DERMATITIS ALLERGIC (skin allergy) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DERMATITIS ALLERGIC (skin allergy). At the time of the report, DERMATITIS ALLERGIC (skin allergy) had not resolved.            No concomitant medications were provided. No treatment medications were provided.  Patient was experiencing skin allergy for more than 2 weeks since the Moderna booster, and also stated that he never had an allergic reaction like this.
Presented to ER with red, hot lesion on right thigh.  Given Motrin/Benadryl and cool compresses to site.
fatique, headaches (still have them. They go from one side of head to the other), swollen hands (continuing issue), bone spur on foot (7/10/21), sores in mouth (June 2021), bulging left eye ( June 2021). None of these issues have been resolved. Something new every week. Body's immune system is under attack. I  had none of these issues prior to the 2nd vaccination. The first vaccination I got severe covid arm.
ON 4/4/21, THE PATIENT REPORTED THAT HER TONGUE SWELLED TO THE POINT SHE THOUGHT SHE WOULD CHOKE.  SHE WENT TO THE ER AND WAS ADMITTED OVERNIGHT FOR TREATMENT.  SHE STATED THAT HER PCP THOUGHT IT WAS AN ADVERSE REACTION TO HER BP MED (LISINOPRIL).  SHE DID NOT REPORT GETTING THE SECOND DOSE OF MODERNA VACCINE TO HER PCP AT THAT TIME.  SHE SAYS SHE IS PLANNING TO TELL HER PCP AT HER FOLLOW-UP APPT THIS WEEK.
Contracted COVID/COVID-19 positive; Contracted COVID/COVID-19 positive; sinuses felt weird; This is a spontaneous report from a contactable consumer.  A 23-year-old (also the age at time of vaccination) male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), in Apr2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE and then in Apr2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE both given intramuscularly for COVID-19 immunization at the Pharmacy or Drug Store. Medical history included cat and dog allergy. Concomitant medications were not reported. The patient had no COVID prior vaccination. In Sep2021, the patient mentioned that he contracted COVID as his sinuses "felt weird", dry throat, and mild headache. The patient had positive COVID-19 test in Sep2021. He had negative COVID-19 test in Sep2020, Jan2021, Feb2021, Apr2021 and May 2021. The patient did not received any treatment for the events and recovered in 2021.   Information regarding the lot/batch number has been requested.
Sm red hives chest/neck/back and Lt leg.  Benadryl 25mg IM, Monitored X15mins.  Hives disapeared after med given.
Patient's arm became red, painful, swollen, with red streak running down arm. She started to develop fever. She went to doctor (unknown which date), and received a prescription for KEFLEX. They told her arm appeared infected.
Chills Body aches Sore joints Fever 100.5F Nausea Fatigue Brain fog Lasted 48 hours
Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No Treatment medications were reported.
Within about an hour headache and mild pain at the injection site, around 4:30/5PM all other symptoms hit: chills, fever, fatigue, runny nose and diarrhea, joint and muscle pain, very sweaty and clammy skin
Patient was given Moderna vaccine by mistake when they should have received a pfizer booster dose. Patient was notified.  Patient is aware to report any adverse effects to us or primary care doctor.  Patient was told not to reschedule for a "third" dose.
Received flu vaccine on 11/5/14 in (L) deltoid. Injection placed in early afternoon and she returned to work station directly afterward. After arriving home a few hours later (3 hrs) she noticed tenderness in (L) deltoid then on assessment saw redness. Has not affected ROM (L) limb. Has sought no medical follow-up declines offer of referral to Occ Med.